Linda Bauld is professor of health policy, director of the Institute for Social Marketing, and dean of research (impact) at the University of Stirling. She is also deputy director of the UK Centre for Tobacco and Alcohol Studies, a UKCRC Centre for Public Health Excellence covering 13 universities. In 2014 she took on the additional role of Cancer Research UK’s cancer prevention champion (the CRUK/BUPA Chair in Behavioural Research for Cancer Prevention). Around 4 in 10 cancers in the UK could be prevented by reducing tobacco and alcohol use, obesity, and other modifiable risk factors, and Bauld’s role is to promote and further develop CRUK’s program of research and policy work on these issues. Her own research focuses primarily on tobacco and alcohol policy with a particular interest in smoking cessation. She is a former scientific adviser on tobacco control to the UK government and a member of a number of policy and research funding committees in Scotland and England.

Andrea Villanti is director for regulatory science and policy at the Schroeder Institute for Tobacco Research and Policy Studies at Truth Initiative. She also holds an adjunct faculty appointment at the Johns Hopkins Bloomberg School of Public Health.

Villanti’s primary focus is on translational research to improve tobacco control policy and program decision-making. Her area of expertise is in young adult tobacco use. She is the principal investigator on Truth Initiative’s Young Adult Cohort Study and has a two-year study, funded by the National Cancer Institute, to examine social smoking in young adults. She is also a collaborating research scientist on a five-year study, funded by the National Institute on Drug Abuse and the Food and Drug Administration, to examine the impact of FDA regulations on tobacco products.

She received her doctorate in social and behavioral sciences from the Johns Hopkins University and her master’s in public health from Columbia University.

Ronald Bayer, PhD, focuses his research on issues of social justice and ethical matters related to AIDS, tuberculosis, illicit drugs, and tobacco. He is an elected member of the Institute of Medicine of the US National Academy of Sciences, and has served on its committees dealing with the social impact of AIDS, tuberculosis elimination, vaccine safety, smallpox vaccination, and the Ryan White Care Act. Bayer has been a consultant to the World Health Organization on ethical issues related to public health surveillance, HIV, and tuberculosis. His articles have appeared in the New England Journal of Medicine, the Journal of the American Medical Association, The Lancet, the American Journal of Public Health, and The Milbank Quarterly.